Reuters

Eurofins Successfully Prices New €600m 7-Year 4%-Coupon Senior Unsecured Bonds

Retrieved on: 
Tuesday, June 21, 2022
Biotechnology, Pharmaceutical, Health, Clinical Trials, Time, European Parliament, Laboratory, Contract, ISIN, COVID-19, Safety, Genomics, US, Environment, Vaccine, CEO, Comment, Reuters, European, Biotechnology, Securities Act of 1933, Council, Travel, Drug Quality and Security Act, Pharmacology, Life, Food, Fitch, BBB, Group, Patient, Judgement, Security (finance), Medical device, Bond, Regulation, Eurofins Scientific, EU

Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3/positive by Moodys and BBB/stable- by Fitch, Eurofins), a global leader in bioanalytical testing, announces that it has successfully raised 600m in its latest senior unsecured Euro-denominated public bond issuance (the Bonds).

Key Points: 
  • Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3/positive by Moodys and BBB/stable- by Fitch, Eurofins), a global leader in bioanalytical testing, announces that it has successfully raised 600m in its latest senior unsecured Euro-denominated public bond issuance (the Bonds).
  • The Bonds have a 7-year maturity (due on 6 July 2029) and will bear an annual fixed rate coupon of 4%.
  • The Bonds will be listed from their issue date (29 June 2022) on the regulated market of the Luxembourg stock exchange (ISIN XS2491664137).
  • Shares in Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0014000MR3, Reuters EUFI.PA, Bloomberg ERF FP).

AHF to Urge CDC, L.A. County Health Dept. to Revisit Condom Use

Retrieved on: 
Monday, June 20, 2022
Other Health, General Health, Pharmaceutical, Public Safety, White House, Federal Government, State, Local, Infectious Diseases, Public Policy, Advocacy Group Opinion, AIDS, Health, Public Policy, Government, Chlamydia, World, WHO, Los Angeles County Department of Public Health, Partner (business rank), Reuters, AIDS Healthcare Foundation, STD, AHF, Vertically transmitted infection, Monkeypox, News, Korea Disease Control and Prevention Agency, World Health Organization, HIV, Patient, Facebook, Semen, AIDS, CDC, COVID, Center, Public health, Birth control, Vaccine

Separately, the CDC reported last year that STDs reached an all-time high for the sixth consecutive year.

Key Points: 
  • Separately, the CDC reported last year that STDs reached an all-time high for the sixth consecutive year.
  • Health officials working in testing and prevention across the country report this trend appears to be continuing.
  • Until or unless the possible sexual transmission of monkeypox is ruled out, condom use remains a prudent public health approach that should be embraced and encouraged by health officials everywhere, added Weinstein.
  • To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth , follow us @aidshealthcare or subscribe to our AHF podcast AHFter Hours.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pegasystems, Humbl, Okta, and Enservco and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, June 20, 2022
Reuters, Circuit court, Securities Act of 1933, U.S. Securities and Exchange Commission, Wisconsin circuit courts, GLOBE, Disclosure, Complaint, Solution, File, Appian Corporation, Annual report, Mission statement, Class Action, NASDAQ, News, SEC, ETX, Twitter, Income, Lawsuit, Exchange, LLC, Hacking, CNN, ERCS, University, Defendant, NYSE, Securities Exchange Act of 1934, Government, Relevant, Coronavirus, Lists of schools in England, Company, Research, OKTA, Economy, Form 10-K, Risk management, Online gambling, Insurance, Public relations, Renewable energy, Audit, Cryptocurrency, Bank, Pegasystems, Conduct, P.C, Humble Bundle, Okta

stealing, seeking confidential information from a new employee who recently worked for a competitor, or misrepresenting your identity in hopes of obtaining confidential information.

Key Points: 
  • stealing, seeking confidential information from a new employee who recently worked for a competitor, or misrepresenting your identity in hopes of obtaining confidential information.
  • The Appian complaint alleged efforts by PEGA to obtain Appian trade secrets through the contractors employee, who had access to Appians software and materials.
  • For more information on the Enservco class action go to: https://bespc.com/cases/ENSV
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors

Retrieved on: 
Thursday, June 16, 2022
Financial Times, Hindenburg Research, Industry, FDA, The Wall Street Journal, Research report, Information technology, Office of Inspector General, U.S. Department of Health and Human Services, Publication, Associated Press, Press, Person, Insurance, Program, NASDAQ, News, SEC, DOJ, Hindenburg, Bloomberg Businessweek, U.S. Department of Justice Office of Legislative Affairs, Justice, GPM, GLOBE, SCAS, Real estate investment trust, Private investigator, Pharmaceutical industry, Forbes, Reuters, Enochian

LOS ANGELES, June 16, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ: ENOB ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • LOS ANGELES, June 16, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ: ENOB ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, Enochians stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, thereby injuring investors.
  • On this news, Enochians stock fell $1.49, or 28.4%, to close at $3.77 on June 1, 2022, thereby injuring investors further.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Unilever PLC (UL) on Behalf of Investors

Retrieved on: 
Thursday, June 16, 2022
Class Action Lawsuit, Professional Services, Legal, Financial Times, Ice cream, Contract, Industry, FDA, The Wall Street Journal, ADR, Information technology, Unilever, Publication, Associated Press, Press, Person, Insurance, UL, Letter, Program, News, SEC, DOJ, Legislation, CNBC, Bloomberg Businessweek, Movement, American, NYSE, GPM, SCAS, Real estate investment trust, Pharmaceutical industry, Forbes, Reuters

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Unilever PLC (Unilever or the Company) (NYSE: UL ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Unilever PLC (Unilever or the Company) (NYSE: UL ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, the Companys American Depositary Receipt (ADR) price fell $0.58 per ADR, or 1%.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Inotiv, Inc. (NOTV) on Behalf of Investors

Retrieved on: 
Thursday, June 16, 2022
Professional Services, Class Action Lawsuit, Financial Times, Industry, FDA, The Wall Street Journal, Animal Welfare Act of 1966, Information technology, U.S. Department of Commerce Office of Security, Publication, Associated Press, Press, Person, Insurance, Seizure, Animal welfare, Program, NASDAQ, News, SEC, DOJ, Bloomberg Businessweek, U.S. Department of Justice Office of Legislative Affairs, Justice, GPM, SCAS, Real estate investment trust, Pharmaceutical industry, Forbes, Reuters

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Inotiv, Inc. (Inotiv or the Company) (NASDAQ: NOTV ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Inotiv, Inc. (Inotiv or the Company) (NASDAQ: NOTV ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, Inotivs stock fell $5.19, or 28.3%, to close at $13.14 per share on May 23, 2022, thereby injuring investors.
  • Whistleblower Notice: Persons with non-public information regarding Inotiv should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Anaplan, Inc. (PLAN) on Behalf of Investors

Retrieved on: 
Thursday, June 16, 2022
Class Action Lawsuit, Professional Services, Legal, Financial Times, Thoma Bravo, Industry, FDA, The Wall Street Journal, Information technology, Publication, Associated Press, Compliance, Press, Person, Insurance, Program, News, SEC, DOJ, Bloomberg Businessweek, NYSE, GPM, SCAS, Real estate investment trust, Online gambling, Pharmaceutical industry, Anaplan, Forbes, Reuters

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Anaplan, Inc. (Anaplan or the Company) (NYSE: PLAN ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Anaplan, Inc. (Anaplan or the Company) (NYSE: PLAN ) investors concerning the Companys possible violations of the federal securities laws.
  • Then, on June 6, 2022, Anaplan announced that the transaction had been amended such that stockholders will receive $63.75 per share.
  • The amendment was to resolve a disagreement between the parties regarding Anaplans compliance with certain terms of the original agreement.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Target Corporation (TGT) on Behalf of Investors

Retrieved on: 
Thursday, June 16, 2022
Class Action Lawsuit, Professional Services, Legal, Financial Times, Industry, FDA, The Wall Street Journal, Target Corporation, Information technology, Publication, Associated Press, Press, Person, Company, Insurance, Program, Investment, News, SEC, DOJ, Bloomberg Businessweek, TGT, NYSE, GPM, Target, Income, Real estate investment trust, SCAS, Pharmaceutical industry, Forbes, Reuters

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Target Corporation (Target or the Company) (NYSE: TGT ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Target Corporation (Target or the Company) (NYSE: TGT ) investors concerning the Companys possible violations of the federal securities laws.
  • On May 18, 2022, Target announced its first quarter 2022 financial results in a press release.
  • On this news, Targets stock fell $3.69, or 2.3%, to close at $155.98 per share on June 7, 2022, thereby injuring investors.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors

Retrieved on: 
Thursday, June 16, 2022
Class Action Lawsuit, Professional Services, Legal, Financial Times, Industry, Review, FDA, The Wall Street Journal, Information technology, Publication, Regulation of tobacco by the U.S. Food and Drug Administration, Associated Press, Press, Person, Company, Insurance, Program, NASDAQ, News, SEC, DOJ, Food, Bloomberg Businessweek, GPM, SCAS, Real estate investment trust, Medical device, Pharmaceutical industry, Forbes, Reuters

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Outset Medical, Inc. (Outset or the Company) (NASDAQ: OM ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Outset Medical, Inc. (Outset or the Company) (NASDAQ: OM ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, Outsets stock fell $6.95, or 34.1%, to close at $13.46 per share on June 14, 2022, thereby injuring investors.
  • Whistleblower Notice: Persons with non-public information regarding Outset should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Reuters Events Free Webinar: GM, VW and Hyundai Reveal Their Blueprint to Automotive's Decade of Transformation

Retrieved on: 
Wednesday, June 15, 2022
Solution, General Motors, Industry, Reuters, Senior, Safety, Volkswagen, Original equipment manufacturer, Technology, Renewable energy, Risk management, Hyundai

That's why Reuters Events are bringing together key strategists from Hyundai, General Motors, and Volkswagen for what is sure to be a must-listen webinar.

Key Points: 
  • That's why Reuters Events are bringing together key strategists from Hyundai, General Motors, and Volkswagen for what is sure to be a must-listen webinar.
  • Sign up for this free session on July 21st at 11am EDT now.
  • The importance of offering resilience and stability within your supply chain to ensure consistency on costs and affordability.
  • The need to explore and establish robust electrical infrastructure and charge points to meet the needs of a new generation of electric vehicles.